• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向MUC1-C可抑制多发性骨髓瘤中的多梳抑制复合物1 。

Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.

作者信息

Tagde Ashujit, Markert Tahireh, Rajabi Hasan, Hiraki Masayuki, Alam Maroof, Bouillez Audrey, Avigan David, Anderson Kenneth, Kufe Donald

机构信息

Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

出版信息

Oncotarget. 2017 Aug 10;8(41):69237-69249. doi: 10.18632/oncotarget.20144. eCollection 2017 Sep 19.

DOI:10.18632/oncotarget.20144
PMID:29050200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5642475/
Abstract

The polycomb repressive complex 1 (PRC1) includes the BMI1, RING1 and RING2 proteins. BMI1 is required for survival of multiple myeloma (MM) cells. The MUC1-C oncoprotein is aberrantly expressed by MM cells, activates MYC and is also necessary for MM cell survival. The present studies show that targeting MUC1-C with (i) stable and inducible silencing and CRISPR/Cas9 editing and (ii) the pharmacologic inhibitor GO-203, which blocks MUC1-C function, downregulates BMI1, RING1 and RING2 expression. The results demonstrate that MUC1-C drives transcription by a MYC-dependent mechanism. MUC1-C thus promotes MYC occupancy on the promoter and thereby activates BMI1 expression. We also show that the MUC1-C→MYC pathway induces RING2 expression. Moreover, in contrast to BMI1 and RING2, we found that MUC1-C drives RING1 by an NF-κB p65-dependent mechanism. Targeting MUC1-C and thereby the suppression of these key PRC1 proteins was associated with downregulation of the PRC1 E3 ligase activity as evidenced by decreases in ubiquitylation of histone H2A. Targeting MUC1-C also resulted in activation of the PRC1-repressed tumor suppressor genes, and . These findings identify a heretofore unrecognized role for MUC1-C in the epigenetic regulation of MM cells.

摘要

多梳抑制复合物1(PRC1)包含BMI1、RING1和RING2蛋白。BMI1是多发性骨髓瘤(MM)细胞存活所必需的。MUC1-C癌蛋白在MM细胞中异常表达,激活MYC,也是MM细胞存活所必需的。目前的研究表明,用(i)稳定且可诱导的沉默和CRISPR/Cas9编辑以及(ii)阻断MUC1-C功能的药物抑制剂GO-203靶向MUC1-C,可下调BMI1、RING1和RING2的表达。结果表明,MUC1-C通过MYC依赖性机制驱动转录。因此,MUC1-C促进MYC在启动子上的占据,从而激活BMI1的表达。我们还表明,MUC1-C→MYC途径诱导RING2的表达。此外,与BMI1和RING2不同,我们发现MUC1-C通过NF-κB p65依赖性机制驱动RING1。靶向MUC1-C从而抑制这些关键的PRC1蛋白与PRC1 E3连接酶活性的下调有关,这通过组蛋白H2A泛素化的减少得到证明。靶向MUC1-C还导致PRC1抑制的肿瘤抑制基因的激活。这些发现揭示了MUC1-C在MM细胞表观遗传调控中迄今未被认识的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/ec90e81aa257/oncotarget-08-69237-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/126a29c839d5/oncotarget-08-69237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/e9692ce07f2c/oncotarget-08-69237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/9cd18a2587ba/oncotarget-08-69237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/6bf76bef1897/oncotarget-08-69237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/c5fa4668542a/oncotarget-08-69237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/f4a4d77fd042/oncotarget-08-69237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/ec90e81aa257/oncotarget-08-69237-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/126a29c839d5/oncotarget-08-69237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/e9692ce07f2c/oncotarget-08-69237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/9cd18a2587ba/oncotarget-08-69237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/6bf76bef1897/oncotarget-08-69237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/c5fa4668542a/oncotarget-08-69237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/f4a4d77fd042/oncotarget-08-69237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dbf/5642475/ec90e81aa257/oncotarget-08-69237-g007.jpg

相似文献

1
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.靶向MUC1-C可抑制多发性骨髓瘤中的多梳抑制复合物1 。
Oncotarget. 2017 Aug 10;8(41):69237-69249. doi: 10.18632/oncotarget.20144. eCollection 2017 Sep 19.
2
MUC1-C activates BMI1 in human cancer cells.MUC1-C在人类癌细胞中激活BMI1。
Oncogene. 2017 May 18;36(20):2791-2801. doi: 10.1038/onc.2016.439. Epub 2016 Nov 28.
3
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.MUC1-C 激活多梳抑制复合物并下调人类癌细胞中的肿瘤抑制基因。
Oncogene. 2018 Apr;37(16):2079-2088. doi: 10.1038/s41388-017-0096-9. Epub 2018 Jan 30.
4
MUC1-C drives MYC in multiple myeloma.MUC1-C在多发性骨髓瘤中驱动MYC。
Blood. 2016 May 26;127(21):2587-97. doi: 10.1182/blood-2015-07-659151. Epub 2016 Feb 23.
5
Role of Bmi1 in H2A ubiquitylation and Hox gene silencing.Bmi1在H2A泛素化和Hox基因沉默中的作用。
J Biol Chem. 2006 Aug 11;281(32):22537-44. doi: 10.1074/jbc.M600826200. Epub 2006 Jun 4.
6
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.MUC1-C在急性髓系白血病中诱导DNA甲基转移酶1并抑制肿瘤抑制基因。
Oncotarget. 2016 Jun 28;7(26):38974-38987. doi: 10.18632/oncotarget.9777.
7
Evolution and conservation of polycomb repressive complex 1 core components and putative associated factors in the green lineage.绿色植物谱系中多梳抑制复合体1核心组分及假定相关因子的进化与保守性
BMC Genomics. 2019 Jun 28;20(1):533. doi: 10.1186/s12864-019-5905-9.
8
Role of histone H2A ubiquitination in Polycomb silencing.组蛋白H2A泛素化在多梳蛋白介导的基因沉默中的作用。
Nature. 2004 Oct 14;431(7010):873-8. doi: 10.1038/nature02985. Epub 2004 Sep 22.
9
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.多梳蛋白家族癌基因EZH2、BMI1和RING1在具有不良病理和临床特征的前列腺癌中过表达。
Eur Urol. 2007 Aug;52(2):455-63. doi: 10.1016/j.eururo.2006.11.020. Epub 2006 Nov 17.
10
A Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage Response.肿瘤发生的一个新方面——BMI1在调节DNA损伤反应中的作用
Biomolecules. 2015 Dec 1;5(4):3396-415. doi: 10.3390/biom5043396.

引用本文的文献

1
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy.基于 CRISPR 的基因编辑技术综述:机制、挑战及在癌症治疗中的应用。
Mol Cancer. 2024 Jan 9;23(1):9. doi: 10.1186/s12943-023-01925-5.
2
The multifaceted role of MUC1 in tumor therapy resistance.MUC1 在肿瘤治疗耐药中的多效性作用。
Clin Exp Med. 2023 Sep;23(5):1441-1474. doi: 10.1007/s10238-022-00978-y. Epub 2022 Dec 23.
3
Role of Polycomb Complexes in Normal and Malignant Plasma Cells.多梳复合物在正常和恶性浆细胞中的作用。

本文引用的文献

1
MUC1-C activates BMI1 in human cancer cells.MUC1-C在人类癌细胞中激活BMI1。
Oncogene. 2017 May 18;36(20):2791-2801. doi: 10.1038/onc.2016.439. Epub 2016 Nov 28.
2
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.靶向抑制BMI1可抑制CEBPα表达低的肺腺癌的肿瘤生长。
Sci Transl Med. 2016 Aug 3;8(350):350ra104. doi: 10.1126/scitranslmed.aad6066.
3
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.MUC1-C在急性髓系白血病中诱导DNA甲基转移酶1并抑制肿瘤抑制基因。
Int J Mol Sci. 2020 Oct 28;21(21):8047. doi: 10.3390/ijms21218047.
4
Latest developments in MUC1 immunotherapy.MUC1 免疫疗法的最新进展。
Biochem Soc Trans. 2018 Jun 19;46(3):659-668. doi: 10.1042/BST20170400. Epub 2018 May 21.
5
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.靶向 MUC1-C 可抑制三阴性乳腺癌中的 BCL2A1。
Signal Transduct Target Ther. 2018 May 12;3:13. doi: 10.1038/s41392-018-0013-x. eCollection 2018.
6
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.MUC1-C 激活多梳抑制复合物并下调人类癌细胞中的肿瘤抑制基因。
Oncogene. 2018 Apr;37(16):2079-2088. doi: 10.1038/s41388-017-0096-9. Epub 2018 Jan 30.
Oncotarget. 2016 Jun 28;7(26):38974-38987. doi: 10.18632/oncotarget.9777.
4
MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.MUC1-C在三阴性乳腺癌细胞对BCL-2抑制剂的氧化应激反应中稳定MCL-1。
Sci Rep. 2016 May 24;6:26643. doi: 10.1038/srep26643.
5
DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells.在人类癌细胞中,由MUC1-C癌蛋白驱动,DNA甲基转移酶DNMT1和DNMT3b进行DNA甲基化。
Oncogene. 2016 Dec 15;35(50):6439-6445. doi: 10.1038/onc.2016.180. Epub 2016 May 23.
6
A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.一个miR-200c/141-BMI1自调控环调节癌细胞中BMI1的致癌活性。
Oncotarget. 2016 Jun 14;7(24):36220-36234. doi: 10.18632/oncotarget.8811.
7
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.胱氨酸/谷氨酸反向转运体、CD44v和MUC1-C癌蛋白在三阴性乳腺癌细胞中的功能相互作用。
Oncotarget. 2016 Mar 15;7(11):11756-69. doi: 10.18632/oncotarget.7598.
8
MUC1-C drives MYC in multiple myeloma.MUC1-C在多发性骨髓瘤中驱动MYC。
Blood. 2016 May 26;127(21):2587-97. doi: 10.1182/blood-2015-07-659151. Epub 2016 Feb 23.
9
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.抑制MUC1-C可抑制MYC表达并减弱KRAS突变型肺腺癌的恶性生长。
Cancer Res. 2016 Mar 15;76(6):1538-48. doi: 10.1158/0008-5472.CAN-15-1804. Epub 2016 Feb 1.
10
Targeting Polycomb systems to regulate gene expression: modifications to a complex story.靶向多梳系统以调控基因表达:复杂故事的修正
Nat Rev Mol Cell Biol. 2015 Nov;16(11):643-649. doi: 10.1038/nrm4067. Epub 2015 Sep 30.